Certainly, another step forward.
This may [will?] be good for people, in the last quarter of 2021. That's why I again say, it's NOT that we treat "Covid 19" it's the TYPE of lung [ARDS] disease our technology may be able to treat, the Covid-19 horse has long bolted, so far as PAA is concerned, it's similar conditions, EVERY Year, that MPL may help - that's the important thing we need to know - NOT "Covid-19" specifically!
Money EVERY Year, from a range of diseases, that can impact like Covid-19 does, is way more profitable than going after "Covid-19" specifically, it's simply a good test target. But others will get to the Covid-19 dance, well before PAA does.
Ann: Inhibition of SARS-CoV-2 by MPL in Human Respiratory Cells, page-60
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $99.71M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $66.86K | 327.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7750 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 84999 | 3 |
View Market Depth
| Last trade - 14.42pm 27/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |